The Quinine Thiourea-Catalyzed Asymmetric Strecker Reaction
HPLC analysis (Daicel Chiralcel AD-H column, hexane/2-
propanol 60: 40, 1.0 mLminÀ1); retention times: tmajor =10.4
and tminor =14.2 min. [a]2D6: +68 (c 1.0, CHCl3). 1H NMR
(300 MHz, CDCl3): d=7.84 (d, J=7.5 Hz, 1H), 7.44 (td, J=
7.8, 1.2 Hz, 1H), 7.19 (td, J=7.5, 0.9 Hz, 1H), 6.91 (d, J=
7.8 Hz, 1H), 5.62 (s, 1H), 3.29 (s, 3H), 1.41 (s, 9H);
13C NMR (75 MHz, CDCl3) d=167.9, 153.6, 143.0, 131.4,
126.2, 124.7, 124.3, 114.6, 109.3, 82.3, 54.6, 28.1, 27.3; IR
(KBr): u=3315, 2978, 2927, 2247, 1742, 1719, 1612, 1492,
1473, 1369, 1255, 1160, 755 cmÀ1; HR-MS (ESI): m/z=
310.1164, calcd. for C15H17N3NaO3 [M+Na]+: 310.1168.
(S)-tert-Butyl (3-cyano-1-methyl-2-oxoindolin-3-yl)carba-
mate (2a’): According to the general procedure, except for
using L4 as the catalyst, compound 2a’ was obtained as
a pale yellow solid; yield: 27.0 mg (94%); mp 157–1588C.
93% ee was determined by HPLC analysis (Daicel Chiralcel
AD-H column, hexane/2-propanol 60: 40, 1.0 mLminÀ1): re-
tention times: tmajor =10.5 and tminor =14.4 min. [a]2D6: À66 (c
1.0, CHCl3). 1H NMR (300 MHz, CDCl3): d=7.83 (d, J=
7.4 Hz, 1H), 7.44 (td, J=7.8, 1.3 Hz, 1H), 7.18 (td, J=7.7,
1.0 Hz, 1H), 6.91 (d, J=7.8 Hz, 1H), 5.62 (s, 1H), 3.29 (s,
3H), 1.41 (s, 9H); 13C NMR (75 MHz, CDCl3): d=167.9,
153.6, 143.0, 131.4, 126.2, 124.7, 124.3, 114.6, 109.3, 82.3,
54.6, 28.1, 27.3; IR (KBr): u=3310, 2977, 2928, 2247, 1741,
1719, 1612, 1492, 1473, 1369, 1254, 1159, 755 cmÀ1; HR-MS
(ESI): m/z=310.1163, calcd. for C15H17N3NaO3 [M+Na]+:
310.1162.
8.73 (s, 1H), 7.72 (d, J=7.6 Hz, 1H), 7.35 (td, J=7.8,
1.2 Hz, 1H), 7.15 (td, J=7.7, 0.9 Hz, 1H), 6.91 (d, J=
7.8 Hz, 1H), 5.91 (s, 1H), 1.42 (s, 9H); 13C NMR (75 MHz,
CDCl3): d=169.6, 153.6, 140.3, 131.4, 125.9, 125.0, 124.2,
114.3, 111.2, 82.7, 55.0, 28.1; IR (KBr): u=3289, 2979, 2928,
2249, 1746, 1620, 1474, 1369, 1254, 1158, 753 cmÀ1; HR-MS
(ESI): m/z=296.1006, calcd. for C14H15N3NaO3 [M+Na]+:
296.1006.
(R)-tert-Butyl (4-chloro-3-cyano-1-methyl-2-oxoindolin-3-
yl)carbamate (2b): According to the general procedure com-
pound 2b was obtained as a white solid; yield: 31.2 mg
(97%); mp 194–1958C. 62% ee was determined by HPLC
analysis (Daicel Chiralcel AD-H column, hexane/2-propanol
80: 20, 1.0 mLminÀ1): retention times: tmajor =22.0 and tminor
=
19.6 min. [a]26: +38 (c 1.0, CHCl3). 1H NMR (300 MHz,
CDCl3): d=7D.38 (t, J=8.1 Hz, 1H), 7.10 (dd, J=8.3, 0.5 Hz,
1H), 6.82 (dd, J=7.9, 0.5 Hz, 1H), 5.89 (s, 1H), 3.30 (s,
3H), 1.32 (s, 9H); 13C NMR (75 MHz, CDCl3) d=167.1,
152.4, 145.2, 132.4, 131.2, 124.4, 120.3, 112.8, 107.7, 82.3,
54.9, 28.0, 27.6; IR (KBr): u=3307, 2979, 2927, 2249, 1751,
1707, 1607, 1459, 1290, 1122, 1033, 764 cmÀ1. HR-MS (ESI):
m/z=344.0778, calcd. for C15H16ClN3NaO3 [M+Na]+:
344.0778.
(R)-tert-Butyl (4-bromo-3-cyano-1-methyl-2-oxoindolin-3-
yl)carbamate (2c): According to the general procedure com-
pound 2c was obtained as a yellow solid; yield: 28.6 mg
(78%); mp 211–2128C. 60% ee was determined by HPLC
analysis (Daicel Chiralcel AD-H column, hexane/2-propanol
(R)-tert-Butyl (1-benzyl-3-cyano-2-oxoindolin-3-yl)carba-
mate (3a): According to the general procedure, compound
3a was obtained as a yellow solid; yield: 35.6 mg (98%); mp
190–1928C. 93% ee was determined by HPLC analysis
(Daicel Chiralcel OD-H column, hexane/2-propanol 96: 4,
80: 20, 1.0 mLminÀ1): retention time: tmajor =27.0 and tminor
=
23.2 min. [a]2D6: +29 (c 1.0, CHCl3). 1H NMR (300 MHz,
CDCl3): d=7.34–7.25 (m, 2H), 6.86 (dd, J=7.2, 1.4 Hz,
1H), 5.92 (s, 1H), 3.30 (s, 3H), 1.32 (s, 9H); 13C NMR
(75 MHz, CDCl3): d=167.0, 152.3, 145.4, 132.6, 127.4, 122.0,
119.2, 112.7, 108.3, 82.3, 56.0, 28.0, 27.6; IR (KBr): u=3306,
2979, 2926, 2247, 1747, 1708, 1603, 1457, 1363, 1287, 1157,
1113, 1025, 781, 756 cmÀ1; HR-MS (ESI): m/z=388.0271,
calcd. for C15H16BrN3NaO3 [M+Na]+: 388.0273.
1.0 mLminÀ1); retention times:
tmajor =19.9 and tminor =
18.5 min. [a]26: +46 (c 1.0, CHCl3). 1H NMR (300 MHz,
CDCl3): d=7D.83 (d, J=7.5 Hz, 1H), 7.37–7.27 (m, 6H), 7.13
(td, J=7.7, 0.9 Hz, 1H), 6.76 (d, J=7.8 Hz, 1H), 5.72 (s,
1H), 4.96 (s, 2H), 1.43 (s, 9H); 13C NMR (75 MHz, CDCl3)
d=168.3, 153.6, 142.2, 134.2, 131.2, 129.0, 128.1, 127.2, 126.3,
124.7, 124.3, 114.6, 110.3, 82.4, 54.8, 44.9, 28.1; IR (KBr): u=
3218, 2979, 2928, 2247, 1720, 1611, 1487, 1370, 1278, 1255,
1160, 754, 700 cmÀ1; HR-MS (ESI): m/z=386.1481, calcd.
for C21H21N3NaO3 [M+Na]+: 386.1481.
(R)-tert-Butyl (3-cyano-1-methyl-5-nitro-2-oxoindolin-3-
yl)carbamate (2d): According to the general procedure com-
pound 2d was obtained as a yellow solid; yield: 31.2 mg
(94%); mp 94–958C. 89% ee was determined by HPLC
analysis (Daicel Chiralcel AD-H column, hexane/2-propanol
(R)-tert-Butyl [3-cyano-1-(methoxymethyl)-2-oxoindolin-
3-yl]carbamate (4a): According to the general procedure
compound 4a was obtained as a pale yellow solid; yield:
27.9 mg (88%); mp 149–1518C. 91% ee was determined by
HPLC analysis (Daicel Chiralcel OD-H column, hexane/2-
propanol 95: 5, 1.0 mLminÀ1): retention times: tmajor =11.3
and tminor =14.6 min. [a]2D6: +62 (c 1.0, CHCl3). 1H NMR
(300 MHz, CDCl3): d=7.75 (d, J=7.5 Hz, 1H), 7.43 (td, J=
7.8, 1.2 Hz, 1H), 7.21 (td, J=7.7, 0.9 Hz, 1H), 7.11 (d, J=
7.9 Hz, 1H), 5.79 (s, 1H), 5.19 (s, 2H), 3.40 (s, 3H), 1.40 (s,
9H); 13C NMR (75 MHz, CDCl3): d=168.7, 153.3, 141.4,
131.5, 125.6, 124.7, 124.1, 114.5, 110.8, 82.4, 72.4, 56.8, 55.1,
28.1. IR (KBr): u=3220, 2979, 2932, 2248, 1752, 1719, 1612,
1487, 1368, 1343, 1282, 1252, 1160, 1097, 756 cmÀ1; HR-MS
(ESI): m/z=340.1272, calcd. for C16H19N3NaO4 [M+Na]+:
340.1273.
80: 20, 1.0 mLminÀ1); retention times:
t
t
major =12.4 and
minor =20.3 min. [a]2D6: +50 (c 1.0, CHCl3). 1H NMR
(300 MHz, CDCl3): d=8.62 (d, J=2.2 Hz, 1H), 8.42 (dd, J=
8.7, 2.3 Hz, 1H), 7.05 (d, J=8.7 Hz, 1H), 5.85 (d, J=7.9 Hz,
1H), 3.39 (s, 3H), 1.42 (s, 9H); 13C NMR (75 MHz, CDCl3):
d=168.1, 153.2, 148.5, 144.4, 128.1, 125.2, 121.5, 113.3, 109.2,
83.2, 54.2, 28.1, 27.9; IR (KBr): u=3320, 2979, 2927, 2374,
1756, 1719, 1528, 1493, 1340, 1159, 756 cmÀ1; HR-MS (ESI):
m/z=355.1019, calcd. for C15H16N4NaO5 [M+Na]+:
355.1018.
(R)-tert-Butyl (5-bromo-3-cyano-1-methyl-2-oxoindolin-3-
yl)carbamate (2e): According to the general procedure com-
pound 2e was obtained as a pale yellow solid; yield: 35.9 mg
(98%); mp 175–1778C. 92% ee was determined by HPLC
analysis (Daicel Chiralcel AD-H column, hexane/2-propanol
80: 20, 1.0 mLminÀ1): retention times: tmajor =8.4 and tminor
=
(R)-tert-Butyl (3-cyano-2-oxoindolin-3-yl)carbamate (5a):
According to the general procedure compound 5a was ob-
tained as a yellow solid; yield: 26.0 mg (95%); mp 88–908C.
13.4 min. [a]26: +54 (c 1.0, CHCl3). 1H NMR (300 MHz,
CDCl3): d=7D.96 (s, 1H), 7.57 (dd, J=8.4, 2.0 Hz, 1H), 6.80
(d, J=8.4 Hz, 1H), 5.65 (s, 1H), 3.28 (s, 3H), 1.43 (s, 9H).
13C NMR (75 MHz, CDCl3): d=167.4, 153.5, 142.1, 134.3,
1
[a]2D6: +55 (c 1.0, CHCl3). H NMR (300 MHz, CDCl3): d=
Adv. Synth. Catal. 0000, 000, 0 – 0
ꢁ 2013 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
7
ÞÞ
These are not the final page numbers!